alea-institute/kl3m-data-sample-004-shuffled huggingface dataset:
EXHIBIT 32.1

Certification Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002

The undersigned
President and chief executive officer of First Republic Preferred Capital Corporation (the Company), hereby certifies on the date hereof pursuant to 18 U.S.C. §1350, as adopted pursuant to §906 of the Sarbanes-Oxley Act of
2002, that the Quarterly Report on Form 10-Q for the quarter ended March 31, 2006 (the Form 10-Q), filed concurrently herewith by the Company, fully complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, as amended, and that the information contained in the Form 10-Q fairly presents, in all material respects, the financial condition and results of operations of the Company.



|                   |  |  |  |                         |  |        |  |                                      
|------------------ |  |  |  | ----------------------- |  | ------ |  | -------------------------------------
|                   |  | 
|Date: May 11, 2006 |  |  |  | /s/ JAMES J. BAUMBERGER
|                   |  |  |  |                         |  | Name:  |  | James J. Baumberger                  
|                   |  |  |  |                         |  | Title: |  | President and chief executive officer
INDEPENDENT AUDITORS' CONSENT



The Board of Directors
Ugly Duckling Corporation:


We consent to the  incorporation by reference in the registration  statements of
Ugly Duckling  Corporation  and  subsidiaries  on Form S-3 (File No.  333-31531)
filed as of July 18, 1997, as amended by  pre-effective  Amendment No. 1 to Form
S-3  filed as of July  30,  1997 and Form  S-3  (File  No.  333-22237)  filed as
post-effective  amendment  No. 2 to Form S-1 as of July 18, 1997,  of our report
dated  February  20,  2002,  except  for Note 17 to the  consolidated  financial
statements,  which is as of March 19, 2002, relating to the consolidated balance
sheets of Ugly Duckling Corporation and subsidiaries as of December 31, 2001 and
2000,  and the related  consolidated  statements  of  operations,  stockholders'
equity  and cash  flows for each of the  years in the  three-year  period  ended
December 31, 2001, which report appears in the December 31, 2001,  Annual Report
on Form 10-K of Ugly Duckling  Corporation and subsidiaries and to the reference
to our firm under the heading "Selected Consolidated Financial Data" in the Form
10-K.

                                  /s/ KPMG LLP



Phoenix, Arizona
March 28, 2002
II

104TH CONGRESS

1ST SESSION S. 194

To repeal the Medicare and Medicaid Coverage Data Bank, and for other

purposes.

IN THE SENATE OF THE UNITED STATES

JANUARY 11 (legislative day, JANUARY 10), 1995

Mr. MCCAIN (for himself, Mr. HOLLINGS, Mr. CRAIG, Mr. HATCH, Mr.

HELMS, Mr. ROBB, Mr. MCCONNELL, and Mr. COATS) introduced the

following bill; which was read twice and referred to the Committee on

Finance

A BILL

To repeal the Medicare and Medicaid Coverage Data Bank,

and for other purposes.

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled,

3 SECTION 1. REPEAL OF MEDICARE AND MEDICAID COV4 ERAGE DATA BANK.

5 (a) REPEAL.—

6 (1) IN GENERAL.—Section 13581 of the Omni7 bus Budget Reconciliation Act of 1993 is hereby re8 pealed.
2

•S 194 IS

1 (2) APPLICATION OF THE SOCIAL SECURITY

2 ACT.—The Social Security Act shall be applied and

3 administered as if section 13581 of the Omnibus

4 Budget Reconciliation Act of 1993 (and the amend5 ments made by such section) had not been enacted.

6 (b) STUDY AND REPORT.—

7 (1) STUDY.—The Secretary of Health and

8 Human Services (hereafter in this subsection re9 ferred to as the ‘‘Secretary’’) shall conduct a study

10 on how to achieve the objectives of the data bank de11 scribed in section 1144 of the Social Security Act

12 (as in effect on the day before the date of the enact13 ment of this Act) in the most cost-effective manner,

14 taking into account—

15 (A) the administrative burden of such data

16 bank on private sector entities and govern17 ments,

18 (B) the possible duplicative reporting re19 quirements of the Health Care Financing Ad20 ministration in effect on such date of enact21 ment, and

22 (C) the legal ability of such entities and

23 governments to acquire the required informa24 tion.
3

•S 194 IS

1 (2) REPORT.—The Secretary shall report to the

2 Congress on the results of the study described in

3 paragraph (1) by not later than 180 days after the

4 date of the enactment of this Act.

Æ
EMULEX CORPORATIONID: 95-3342259Notice of Grant of Award
    
    3333 SUSAN STREETand Award Agreement
    
    COSTA MESA, CA 92626
 
 GRANTEE
    
    Award Number:ADDRESS
    
    Plan:
    
    EIPCITY, STATE, ZIP COUNTRY
    
    ID:
 
 
 
  Shares
    
    Full Vest
 
  
 EMULEX CORPORATION
    
    DateGRANTEE
    
    Date
<PAGE>

                                                                    EXHIBIT 23.2

                     [LETTERHEAD OF HUDDLESTON & CO., INC.]


                               LETTER OF CONSENT

  We hereby consent to the references to us under the headings "Principal
Properties" and "Oil and Gas Reserves" in the Annual Report on Form 10-K of
PetroCorp Incorporated for the year ended December 31, 1999.


                                  Huddleston & Co., Inc.

                                  By:    /s/  B. P. Huddleston
                                     --------------------------------------
                                     B. P. Huddleston, P.E.
                                      Chairman

Houston, Texas
March 24, 2000
<PAGE>
 
                                                                  EXHIBIT 3.2.1
 
                           CERTIFICATE OF AMENDMENT
                                      OF
                           ARTICLES OF INCORPORATION
 
  The undersigned certify that:
 
    1. They are the President and Secretary, respectively, of Keystone
  Automotive Industries, Inc., a California corporation.
 
    2. Article Three of the Articles of Incorporation of this corporation be
  amended to read as follows:
 
    Three: This corporation is authorized to issue two classes of shares of
  stock designated "Common Stock" and "Preferred Stock," respectively. The
  total number of shares of stock which this corporation shall have authority
  to issue is 53,000,000 shares, consisting of 50,000,000 shares of Common
  Stock and 3,000,000 shares of "Preferred Stock."
 
    3. The foregoing Amendment of Articles Incorporation has been duly
  approved by the Board of Directors.
 
    4. The foregoing Amendment of Articles of Incorporation has been duly
  approved by the required vote of shareholders in accordance with Section
  902, California Corporations Code. The total number of shares outstanding
  of the corporation is 12,638,052. The number of shares voting in favor of
  the amendment exceeded the vote required. The percentage vote required was
  more than 50%.
 
  We further declare under penalty of perjury under the laws of the State of
California that the matters set forth in this Certificate are true and correct
of our own knowledge.
 
                                                 /s/ Charles J. Hogarty
                                          _____________________________________
                                                    Charles J. Hogarty
                                                         President
 
                                                  /s/ James C. Lockwood
                                          _____________________________________
                                                     James C. Lockwood
                                                         Secretary
 
Date: August 29, 1997
**Exhibit 31.1**

**CERTIFICATION OF PRINCIPAL EXECUTIVEOFFICER**

I, Michael N.Chang, certify that:

1. I have reviewedthis quarterly report on Form 10-Q of Optimer Pharmaceuticals, Inc.;

2. Based on myknowledge, this report does not contain any untrue statement of a material factor omit to state a material fact necessary to make the statements made, inlight of the circumstances under which such statements were made, notmisleading with respect to the period covered by this report;

3. Based on myknowledge, the financial statements, and other financial information includedin this report, fairly present in all material respects the financialcondition, results of operations and cash flows of the registrant as of, andfor, the periods presented in this report;

4. The registrant’sother certifying officer and I are responsible for establishing and maintainingdisclosure controls and procedures (as defined in Exchange ActRules 13a-15(e) and 15d-15(e)) for the registrant and have:

a)              designedsuch disclosure controls and procedures, or caused such disclosure controls andprocedures to be designed under our supervision, to ensure that materialinformation relating to the registrant, including any consolidatedsubsidiaries, is made known to us by others within those entities, particularlyduring the period in which this report is being prepared;

b)             evaluatedthe effectiveness of the registrant’s disclosure controls and procedures andpresented in this report our conclusions about the effectiveness of thedisclosure controls and procedures, as of the end of the period covered by thisreport based on such evaluation; and

c)              disclosedin this report any change in the registrant’s internal control over financialreporting that occurred during the registrant’s most recent fiscal quarter (theregistrant’s fourth fiscal quarter in the case of an annual report) that hasmaterially affected, or is reasonably likely to materially affect, theregistrant’s internal control over financial reporting; and

5. The registrant’sother certifying officer and I have disclosed, based on our most recentevaluation of internal control over financial reporting, to the registrant’sauditors and the audit committee of the registrant’s board of directors (orpersons performing the equivalent functions):

a)              allsignificant deficiencies and material weaknesses in the design or operation ofinternal control over financial reporting which are reasonably likely toadversely affect the registrant’s ability to record, process, summarize andreport financial information; and

b)             anyfraud, whether or not material, that involves management or other employees whohave a significant role in the registrant’s internal control over financialreporting.
| Date: May 10, 2007                     |   |   |
|----------------------------------------|--------|--------|
|                                   |   |   |
| /s/ Michael N.  Chang                  |   |   |   |
| Michael N. Chang                       |   |   |
| President and  Chief Executive Officer |   |   |
|                                        |        |        |  |

 

----
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 FORM 8-K
 CURRENT REPORT
Pursuant to Section 13 or 15(d) of
The Securities Exchange Act of 1934
 November 29, 2007
 TRANS1 INC.
  Delaware
(State or other
jurisdiction of 
incorporation)
    
    001-33744
(Commission File Number)
    
    33-0909022
(IRS Employer
Identification No.)
 411 Landmark Drive
Wilmington, NC 28412-6303
 (910) 332-1700
   o
    
    Written communications pursuant to Rule 425 under the Securities Act
(17 CFR 230.425).o
    
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act
(17 CFR 240.14a-12)o
    
    Pre-commencement communications pursuant to Rule 14d-2(b) under the
Exchange Act (17 CFR 240.14d-2(b))o
    
    Pre-commencement communications pursuant to Rule 13e-4(c) under the
Exchange Act (17 CFR 240.13e-4(c))




---



TABLE OF CONTENTS  Item 5.02 Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.Item 9.01 Financial Statements and Exhibits.SignaturesEXHIBIT INDEXEXHIBIT 99.1    Table of Contents  
 Item 5.02
    
    Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.
 (d)
    
    Appointment of New Director
     
 Item 9.01
    
    Financial Statements and Exhibits.
 (d) Exhibits.
 Exhibit Number
    
    Description99.1
    
    Press release issued by TranS1 Inc., dated December 3, 2007.




---



##### Table of Contents



Signatures
  TRANS1 INC.December 3, 2007
    By:
    /s/ Michael LuetkemeyerMichael LuetkemeyerChief Financial Officer




---



##### Table of Contents



EXHIBIT INDEX
 Exhibit Number
    
    Description99.1
    
    Press release issued by TranS1 Inc., dated December 3, 2007.
##### Table of Contents



UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
 Washington, D.C. 20549
 
 Form 8-K
 CURRENT REPORT
Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934
 May 8, 2008
 SM&A
 
  Delaware
    
    0-23585
    
    33-0080929(State or other jurisdiction 
of incorporation)
    
    (Commission
File Number)
    
    (IRS Employer
Identification No.)4695 MacArthur Court, 8th Floor, Newport Beach, California
    
    92660(Address of principal executive offices)
    
    (Zip Code)
 949) 975-1550
 Not Applicable
  see
 o
    
    Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)o
    
    Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)o
    
    Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR
240.14d-2(b))o
    
    Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR
240.13e-4(c))




---



TABLE OF CONTENTS  Item 2.02 Results of Operations and Financial Condition.Item 9.01 Financial Statements and Exhibits.Exhibit ListSIGNATURESExhibit ListEXHIBTI 99.1    Table of Contents  
 Item 2.02 Results of Operations and Financial Condition.
   
 Item 9.01 Financial Statements and Exhibits.




---



##### Table of Contents



Exhibit List
 Exhibit No.
    
    Description99.1
    
    Press release dated May 8, 2008




---



##### Table of Contents



SIGNATURES
  May 8, 2008
    SM&ABy:
    /s/ James R. EckstaedtName:
    James R. EckstaedtTitle:
    Executive Vice President, Finance
and Chief Financial Officer




---



##### Table of Contents



Exhibit Index
 Exhibit No.
    
    Description99.1
    
    Press release dated May 8, 2008
<TABLE> <S> <C>

<ARTICLE>           5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THERMEDICS
DETECTION INC.'S ANNUAL REPORT ON FORM 10-K FOR THE YEAR ENDED DECEMBER 28, 1996
AND IS QUALIFIED IN ITS ENTIRETY BY REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<MULTIPLIER>        1,000
       
<S>                              <C>
<PERIOD-TYPE>                                 YEAR
<FISCAL-YEAR-END>                             DEC-28-1996
<PERIOD-END>                                  DEC-28-1996
<CASH>                                                 14,264
<SECURITIES>                                                0
<RECEIVABLES>                                          19,043
<ALLOWANCES>                                            1,455
<INVENTORY>                                            14,090
<CURRENT-ASSETS>                                       51,679
<PP&E>                                                  9,071
<DEPRECIATION>                                          5,047
<TOTAL-ASSETS>                                        116,058
<CURRENT-LIABILITIES>                                  19,364
<BONDS>                                                     0
<PREFERRED-MANDATORY>                                       0
<PREFERRED>                                                 0
<COMMON>                                                1,664
<OTHER-SE>                                             73,790
<TOTAL-LIABILITY-AND-EQUITY>                          116,058
<SALES>                                                80,557
<TOTAL-REVENUES>                                       94,604
<CGS>                                                  37,857
<TOTAL-COSTS>                                          45,610
<OTHER-EXPENSES>                                        8,100
<LOSS-PROVISION>                                          642
<INTEREST-EXPENSE>                                      1,119
<INCOME-PRETAX>                                         8,818
<INCOME-TAX>                                            3,519
<INCOME-CONTINUING>                                     5,299
<DISCONTINUED>                                              0
<EXTRAORDINARY>                                             0
<CHANGES>                                                   0
<NET-INCOME>                                            5,299
<EPS-PRIMARY>                                            0.33
<EPS-DILUTED>                                            0.33
        

</TABLE>
##### 



SPARTA, INC.
 EQUITY BONUS PLAN
 ARTICLE I
General
 1.1 Purpose
 1.2 Plan Administration.
   1.3 Definitions
   1




---



##### 



ARTICLE II
Participation
 2.1 Participation
 ARTICLE III
Equity Bonus Payment
 3.1 Equity Bonus Amount.
      2




---



##### 



3.2 Maximum Aggregate Equity Bonus Amount.
 3.3 Equity Bonus Payment.
 3.4 Involuntary Termination
 3.5 Termination of Employment for Other Reasons
 3.6 Reassignment of Participant.
 ARTICLE IV
Amendment or Termination
 4.1 Effectiveness, Amendment and Termination
 3




---



##### 



4.2 Successors
 ARTICLE V
Miscellaneou
 5.1 Set-Off
 5.2 Non-Alienation
 5.3 Withholding
 5.4 Source of Payments
 5.5 Notices
 5.6 Gender and Number
 5.7 No Right to Employment or Continuation of Relationship
 4




---



##### 



5.8 Governing Law
 5.9 Severability
 5.10 No Limitation Upon the Rights of the Company
 5.11 No Liability for Good Faith Determinations
 5
##### 



Exhibit 32.1
 Certification of the Chief Executive Officer
Pursuant to 18 U.S.C. Section 1350,
As Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002
  (1)
    
    The Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and(2)
    
    The information contained in the Report fairly presents, in all material respects, the
financial condition and results of operations of the Company.
  /s/ William D. GreenWilliam D. GreenChief Executive Officer of Accenture Ltd,
General Partner of Accenture SCA
(principal executive officer) A signed original of this written statement required by Section 906, or other document
authenticating, acknowledging, or otherwise adopting the signature that appears in typed form
within the electronic version of this written statement required by Section 906, has been provided
to the Company and will be retained by the Company and furnished to the Securities and Exchange
Commission or its staff upon request.
 34
Electronically Filed 

Supreme Court 

SCWC-13-0000087 

20-MAY-2014 

08:36 AM 

SCWC-13-0000087
 

IN THE SUPREME COURT OF THE STATE OF HAWAI'I 

STATE OF HAWAI'I,


Respondent/Plaintiff-Appellee,
 

vs.
 

JAMES E. ABEL,


Petitioner/Defendant-Appellant.
 

CERTIORARI TO THE INTERMEDIATE COURT OF APPEALS
 

(CAAP-13-0000087; CASE No. 1P1120008541)
 

ORDER ACCEPTING APPLICATION FOR WRIT OF CERTIORARI 


(By: Recktenwald, C.J., Nakayama, McKenna, Pollack, and Wilson, JJ.)
 

Petitioner/Defendant-Appellant James E. Abel’s 

application for writ of certiorari, filed on April 6, 2014, is 

hereby accepted. 

IT IS FURTHER ORDERED, that no oral argument will be 

heard in this case. Any party may, within ten days and pursuant 

to Rule 34(c) of the Hawai'i Rules of Appellate Procedure, move 

for retention of oral argument. 

DATED: Honolulu, Hawai'i, May 20, 2014.
 

James S. Tabe 

for petitioner
 

/s/ Mark E. Recktenwald


/s/ Paula A. Nakayama


Brandon H. Ito
 

for respondent /s/ Sabrina S. McKenna
 

/s/ Richard W. Pollack
 

/s/ Michael D. Wilson
```

[Congressional Bills 104th Congress]
[From the U.S. Government Publishing Office]
[S. 174 Introduced in Senate (IS)]

104th CONGRESS
  1st Session
                                 S. 174

 To repeal the prohibitions against political recommendations relating 
to Federal employment and United States Postal Service employment, and 
                          for other purposes.

_______________________________________________________________________

                   IN THE SENATE OF THE UNITED STATES

                            January 9, 1995

   Mr. Simon introduced the following bill; which was read twice and 
           referred to the Committee on Governmental Affairs

_______________________________________________________________________

                                 A BILL

 
 To repeal the prohibitions against political recommendations relating 
to Federal employment and United States Postal Service employment, and 
                          for other purposes.

    Be it enacted by the Senate and House of Representatives of the 
United States of America in Congress assembled,

SECTION 1. REPEAL OF PROHIBITIONS AGAINST POLITICAL RECOMMENDATIONS 
              RELATING TO FEDERAL EMPLOYMENT AND UNITED STATES POSTAL 
              SERVICE EMPLOYMENT.

    (a) Federal Employment.--(1) Section 3303 of title 5, United States 
Code, is repealed.
    (b) Technical and Conforming Amendments.--(1) The table of sections 
for chapter 33 of title 5, United States Code, is amended by striking 
out the item relating to section 3303.
    (2) Section 2302(b)(2) of title 5, United States Code, is amended 
to read as follows:
            ``(2) solicit or consider any recommendation or statement, 
        oral or written, with respect to any individual who requests or 
        is under consideration for any personnel action unless such 
        recommendation or statement is based on the personal knowledge 
        or records of the person furnishing it and consists of--
                    ``(A) an evaluation of the work performance, 
                ability, aptitude, or general qualifications of such 
                individual; or
                    ``(B) an evaluation of the character, loyalty, or 
                suitability of such individual;''.
                                 <all>
```
<PAGE>   1
 
                                                                    EXHIBIT 23.1
 
                   CONSENT OF INDEPENDENT PUBLIC ACCOUNTANTS
 
     As independent public accountants, we hereby consent to the use of our
reports (and all references to our Firm) included in or made part of this
registration statement.
 
                                          ARTHUR ANDERSEN LLP
 
Orange County, California
October 29, 1996
**EXHIBIT 23.1**

**CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM**

We have issued our report datedMarch 28, 2008, accompanying the consolidated financial statements and related schedule included in the Annual Report of EP MedSystems, Inc. and Subsidiaries on Form 10-K for the year ended December 31, 2007. We hereby consent to theincorporation by reference of said report in the Registration Statements of EP MedSystems, Inc. and Subsidiaries on Forms S-8 (File No. 333-346656, effective April 13, 2000, amended June 29, 2000; File No. 333-122081, effectiveJanuary 14, 2005) and Forms S-3 (File No. 333-104231, effective April 21, 2003; File No. 333-110023, effective November 19, 2003, File No. 333-112131, effective February 4, 2004; File No. 333-120263, effectiveNovember 26, 2004 and File No. 333-122082, effective February 3, 2005; File No. 333-133540 effective June 23, 2006; File No. 333-133558 effective April 26, 2006). 

Philadelphia, Pennsylvania 

March 28, 2008